Status:
UNKNOWN
Migraine Headache Mitigation Utilizing Avulux
Lead Sponsor:
Kaiser Permanente
Conditions:
Migraine
Headache
Eligibility:
All Genders
18-120 years
Phase:
NA
Brief Summary
This will be a randomized double blind cross over interventional trial to determine if Avulux lenses are able to reduce headache symptoms in patients
Detailed Description
Participants: This study will include a total of 40 participants aged 18 and over who have been screened for migraine headache history. Patients who attended the SBC Headache class with a diagnosis o...
Eligibility Criteria
Inclusion
- Patient population: Individuals must have an existing diagnosis code of G43.1 (migraine w aura) or G43. 10 (migraine w aura, not intractable).
- Only Kaiser Permanente members receiving care at the Fontana Medical Service Areas will be in consideration.
- Patients that are \>18
- There will no restrictions based on biological sex.
- Participants will be referred to optical by provider (Neurologists/Optometrist/Primary Care physician).
- Participants must agree to not initiate any new medical management during the trial or be willing to voluntarily withdrawal from participating in the trial
Exclusion
- Patients who do not have a migraine diagnosis code in their medical record.
- Patients that have started a new migraine medication within last 30 days
- Non-Members of Kaiser Permanente
Key Trial Info
Start Date :
December 13 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 20 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06149000
Start Date
December 13 2023
End Date
June 20 2024
Last Update
November 28 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.